Rephonic
Artwork for BiotechTV

BiotechTV - News

BiotechTV
FDA
Biotech
Obesity
Alzheimer's Disease
Clinical Trials
Biotechnology
Breast Cancer
Mergers and Acquisitions
Car-T Therapy
Oncology
Artificial Intelligence
Multiple Myeloma
Parkinson's Disease
Immunology
TYK2
Gene Editing
Gene Therapy
Takeda
Syncona
Rare Disease

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

PublishesDailyEpisodes491Founded2 years ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for BiotechTV

Latest Episodes

President and CEO Malte Peters summarizes the ESMO data for vopemetistat, which was in second and third line pancreatic cancer in combination with daraxonrasib, and discusses plans for a phase 3 in first line (plus the regulatory path for later lines... more

CEO Markus Rohrwild and CDMO Thomas Langenickel provide an update on the company's peptide based drug development side, as well as venture and CRO arms.

CEO John Baker describes how the project, done in collaboration with Ultima Genomics and Waters Corporation, will give researcher a tool to better understand the immune system. He also describes how IMU's blood sample based system works, and how it h... more

CEO Ros Deegan describes the raise and the new investors that it brings into the company, and updates us on the company's pipeline progress.

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

Recent Guests

John Baker
Chief Executive of IMU Biosciences
IMU Biosciences
Episode: London based IMU Biosciences announced today that it will use its immune system profiling platform with 80,000 blood samples from UK Biobank to create a large-scale picture of the human immune system
Ros Deegan
Chief executive of OMass Therapeutics
OMass Therapeutics
Episode: Oxford, UK based OMass Therapeutics announced a $310M series C today, advancing its small molecule platform, including the lead MC2 (melanocortin-2) receptor antagonist that is in phase 1
Cigall Kadoch
Professor of Pediatric Oncology at Dana-Farber and an Investigator of the Howard Hughes Medical Institute
Dana-Farber Cancer Institute
Episode: At Dana-Farber Cancer Institute in Boston, President & CEO Ben Ebert and Professor and Investigator Cigall Kadoch discuss the latest trends in cancer research
Ben Ebert
Physician-scientist and President and CEO of Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Episode: At Dana-Farber Cancer Institute in Boston, President & CEO Ben Ebert and Professor and Investigator Cigall Kadoch discuss the latest trends in cancer research
David Ricks
Chairman and CEO of Eli Lilly
Eli Lilly
Episode: Eli Lilly Chairman & CEO David Ricks discusses GLP-1's, Alzheimer's, business development and more
Alex Zhavoronkov
Chairman and CEO of Insilico Medicine
Insilico Medicine
Episode: After a busy time in Boston during the Aging Research and Drug Discovery Meeting, Insilico Medicine CEO Alex Zhavoronkov discusses the latest in longevity therapeutics and Insilico's pipeline progress
Markus Warmuth
Chief executive of Monte Rosa Therapeutics
Monte Rosa Therapeutics
Episode: Monte Rosa Therapeutics announced data for MRT-8102, its NEK7-directed molecular glue degrader, showing positive impact on biomarkers linked to atherosclerotic cardiovascular disease
Stefanie Fluckiger
Chief Executive, TOLREMO Therapeutics
TOLREMO Therapeutics
Episode: From Basel: TOLREMO Therapeutics is working on cancer resistance - the company believes is targeting CBP/p300 just stared phase 1 data at World Lung
Sascha Oliver Bucher
Co-founder and partner, Forty51 Ventures
Forty51 Ventures
Episode: From Basel: Forty51 Ventures was formed in Basel four years ago and has a company building model - they look globally, but believe that having the pharma company pipeline in Basel is an advantage

Host

Brad
Host conducting interviews and reporting from biotech hubs and industry events.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

At Dana-Farber Cancer Institute in Boston, President & CEO Ben Ebert and Professor and Investigator Cigall Kadoch discuss the latest trends in cancer research
Q: Can you tell us a little bit about what it's been like for you growing up in this environment and how you've been able to transform not only the field of understanding basic epigenetic biology, but how you're helping bring those into therapeutics?
Cigall Kadoch describes studying frequently mutated BAF chromatin-remodeling complexes, building foundational knowledge of their structure and function, and seeking precise disease-specific targets that could reduce toxicity.
At Dana-Farber Cancer Institute in Boston, President & CEO Ben Ebert and Professor and Investigator Cigall Kadoch discuss the latest trends in cancer research
Q: Tell us a little bit about what you're excited about and how Dana-Farber fits into that.
Ben Ebert points to clinical success and FDA approval of a pancreatic cancer therapy and the success of cancer vaccines, emphasizing that both depended on decades of basic science research.
London based IMU Biosciences announced today that it will use its immune system profiling platform with 80,000 blood samples from UK Biobank to create a large-scale picture of the human immune system
Q: Tell us what you're doing with it and how it all came about.
After years of discussions, pilots, and workflow development with UK Biobank, IMU is profiling samples to combine immune measurements with gene-expression data. The resulting dataset may help identify disease and progression signatures, and will eventually be made available through the Biobank's research access platform after an exclusivity period.
London based IMU Biosciences announced today that it will use its immune system profiling platform with 80,000 blood samples from UK Biobank to create a large-scale picture of the human immune system
Q: So physically, what are you doing with the blood samples? I mean, and what's the inputs and the outputs?
IMU stains blood samples with antibody panels, measures 60 to 70 cell-surface proteins across millions of cells, then applies machine learning to interpret the resulting measurements and characterize immune cell types, abundance, and activity.
After a busy time in Boston during the Aging Research and Drug Discovery Meeting, Insilico Medicine CEO Alex Zhavoronkov discusses the latest in longevity therapeutics and Insilico's pipeline progress
Q: What do you do with the aging part of it?
Insilico plans to collect proteomic data in its Phase 3 IPF trial for longer and use a more comprehensive panel. Persistent results across multiple aging clocks could strengthen the case for classifying the drug as a gerotherapeutic.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About BiotechTV

What is BiotechTV about and what kind of topics does it cover?

On the ground biotech coverage, this program centers on live reporting from biotech hubs and in-depth conversations with leaders, investors, and scientists shaping the industry. Episodes typically explore company strategies, clinical progress, funding dynamics, and market implications, often framed around major conferences or regional biotech ecosystems. A distinctive pattern is the frequent pairing of on-site reporting with expert analysis from guests ranging from CEOs and founders to analysts and venture investors, giving listeners actionable insights for investing, partnerships, and business development.

Where can I find podcast stats for BiotechTV?

Rephonic provides a wide range of podcast stats for BiotechTV. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to BiotechTV and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does BiotechTV get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for BiotechTV, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for BiotechTV?

Rephonic provides comprehensive predictive audience data for BiotechTV, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does BiotechTV have?

To see how many followers or subscribers BiotechTV has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to BiotechTV?

These podcasts share a similar audience with BiotechTV:

1. Biotech Hangout
2. BioCentury This Week
3. The Long Run with Luke Timmerman
4. The Readout Loud
5. BioVenture VoiCes with Chris Garabedian

How many episodes of BiotechTV are there?

BiotechTV launched 2 years ago and published 491 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact BiotechTV?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for BiotechTV?

Rephonic pulls ratings and reviews for BiotechTV from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for BiotechTV?

Rephonic provides full transcripts for episodes of BiotechTV. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on BiotechTV?

Recent guests on BiotechTV include:

1. John Baker
2. Ros Deegan
3. Cigall Kadoch
4. Ben Ebert
5. David Ricks
6. Alex Zhavoronkov
7. Markus Warmuth
8. Stefanie Fluckiger

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days